Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
Company profile
Website
CEO
Kenneth C. Frazier
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Merck & Co Inc
SEC CIK
Corporate docs
IRS number
221109110
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
10 Jan 24
DFAN14A
Additional proxy materials by non-management
8 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
11 Jan 23
SC TO-T/A
Third party tender offer statement (amended)
21 Dec 22
SC TO-T
Third party tender offer statement
12 Dec 22
SC TO-C
Information about tender offer
21 Nov 22
SC TO-T/A
Third party tender offer statement (amended)
22 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
17 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
8 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
29 Oct 21
Latest ownership filings
4
Harpoon Therapeutics, Inc.
11 Mar 24
SC 13D/A
Harpoon Therapeutics, Inc.
11 Mar 24
SC 13D
Harpoon Therapeutics, Inc.
18 Jan 24
3
Harpoon Therapeutics, Inc.
17 Jan 24
3
Pandion Therapeutics, Inc.
4 Mar 21
11-K
Annual report of employee stock purchases
29 Jun 09
11-K
Annual report of employee stock purchases
29 Jun 09
11-K
Annual report of employee stock purchases
29 Jun 09
11-K
Annual report of employee stock purchases
25 Jun 09
11-K
Annual report of employee stock purchases
30 Jun 08